Advanced search
Publication Cover
Clinical and Experimental Hypertension Volume 28, 2006 - Issue 7
Submit an article Journal homepage
136
Views
7
CrossRef citations to date
0
Altmetric
Original

Pharmacokinetics and Safety of Olmesartan Medoxomil in Combination with Glibenclamide in Healthy Volunteers

Matthias Huber Department of Clinical Pharmacology and Toxicology, Campus Benjamin Franklin, Charité—Universitätsmedizin Berlin, Berlin, Germany
,
Juliane Bolbrinker Department of Clinical Pharmacology and Toxicology, Campus Benjamin Franklin, Charité—Universitätsmedizin Berlin, Berlin, Germany
&
Reinhold Kreutz Department of Clinical Pharmacology and Toxicology, Campus Benjamin Franklin, Charité—Universitätsmedizin Berlin, Berlin, GermanyCorrespondence[email protected]
Pages 631-643 | Published online: 03 Jul 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Siu Wai Choi & Cyrus K. Ho. (2018) Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy?. Redox Report 23:1, pages 1-24.
Read now
Henry A Punzi. (2009) Efficacy and safety of olmesartan medoxomil alone and in combination with hydrochlorothiazide. Expert Review of Cardiovascular Therapy 7:3, pages 229-239.
Read now
Mark Greathouse. (2008) Olmesartan medoxomil-based therapy for the management of hypertension. Expert Review of Clinical Pharmacology 1:5, pages 593-604.
Read now
Vivencio Barrios & Carlos Escobar. (2008) Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Expert Opinion on Pharmacotherapy 9:1, pages 129-136.
Read now

Articles from other publishers (3)

Martin C. Michel, Carolyn Foster, Hans R. Brunner & Lisheng Liu. (2013) A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists. Pharmacological Reviews 65:2, pages 809-848.
Crossref
Kun-Yan Li, Jian-Ping Liang, Bing-Qiang Hu, Yu Qiu, Chen-Hui Luo, Yun Jiang, Xiao-Ping Lin & Nong Yang. (2010) The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study. Clinical Therapeutics 32:9, pages 1674-1680.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.